These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

885 related articles for article (PubMed ID: 30816337)

  • 21. [Tumor and angiogenesis].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2008; 125(3):487-96; discussion 497-9. PubMed ID: 19505004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are tumours angiogenesis-dependent?
    Verheul HM; Voest EE; Schlingemann RO
    J Pathol; 2004 Jan; 202(1):5-13. PubMed ID: 14694516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mathematical Modelling of a Brain Tumour Initiation and Early Development: A Coupled Model of Glioblastoma Growth, Pre-Existing Vessel Co-Option, Angiogenesis and Blood Perfusion.
    Cai Y; Wu J; Li Z; Long Q
    PLoS One; 2016; 11(3):e0150296. PubMed ID: 26934465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.
    Frentzas S; Simoneau E; Bridgeman VL; Vermeulen PB; Foo S; Kostaras E; Nathan M; Wotherspoon A; Gao ZH; Shi Y; Van den Eynden G; Daley F; Peckitt C; Tan X; Salman A; Lazaris A; Gazinska P; Berg TJ; Eltahir Z; Ritsma L; Van Rheenen J; Khashper A; Brown G; Nystrom H; Sund M; Van Laere S; Loyer E; Dirix L; Cunningham D; Metrakos P; Reynolds AR
    Nat Med; 2016 Nov; 22(11):1294-1302. PubMed ID: 27748747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of vessel co-option lung metastases mouse models for single-cell isolation of metastases-derived cells and endothelial cells.
    Cuypers A; Teuwen LA; Bridgeman VL; de Rooij LPMH; Eelen G; Dewerchin M; Cantelmo AR; Kalucka J; Bouché A; Vinckier S; Carton A; Manderveld A; Vermeulen PB; Reynolds AR; Carmeliet P
    STAR Protoc; 2022 Dec; 3(4):101691. PubMed ID: 36173713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation.
    Qian CN; Tan MH; Yang JP; Cao Y
    Chin J Cancer; 2016 Jan; 35():10. PubMed ID: 26747273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of macrophage polarization in tumor angiogenesis and vessel normalization: implications for new anticancer therapies.
    Chen P; Bonaldo P
    Int Rev Cell Mol Biol; 2013; 301():1-35. PubMed ID: 23317816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-angiogenic tumours unveil a new chapter in cancer biology.
    Pezzella F; Gatter K
    J Pathol; 2015 Feb; 235(3):381-3. PubMed ID: 25351454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hijacking the vasculature in ccRCC--co-option, remodelling and angiogenesis.
    Qian CN
    Nat Rev Urol; 2013 May; 10(5):300-4. PubMed ID: 23459032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour vascularization: sprouting angiogenesis and beyond.
    Hillen F; Griffioen AW
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):489-502. PubMed ID: 17717633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor angiogenesis: causes, consequences, challenges and opportunities.
    Lugano R; Ramachandran M; Dimberg A
    Cell Mol Life Sci; 2020 May; 77(9):1745-1770. PubMed ID: 31690961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration.
    Legg JA; Herbert JM; Clissold P; Bicknell R
    Angiogenesis; 2008; 11(1):13-21. PubMed ID: 18264786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor angiogenesis--characteristics of tumor endothelial cells.
    Hida K; Maishi N; Torii C; Hida Y
    Int J Clin Oncol; 2016 Apr; 21(2):206-212. PubMed ID: 26879652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model.
    Chauvet N; Romanò N; Lafont C; Guillou A; Galibert E; Bonnefont X; Le Tissier P; Fedele M; Fusco A; Mollard P; Coutry N
    Int J Cancer; 2017 May; 140(9):2150-2161. PubMed ID: 28152577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lattice and non-lattice models of tumour angiogenesis.
    Plank MJ; Sleeman BD
    Bull Math Biol; 2004 Nov; 66(6):1785-819. PubMed ID: 15522355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mathematical model of tumour angiogenesis: growth, regression and regrowth.
    Vilanova G; Colominas I; Gomez H
    J R Soc Interface; 2017 Jan; 14(126):. PubMed ID: 28100829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour angiogenesis: the relevance to surgeons.
    Atkin GK; Chopada A
    Ann R Coll Surg Engl; 2006 Oct; 88(6):525-9. PubMed ID: 17059709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour angiogenesis-Origin of blood vessels.
    Krishna Priya S; Nagare RP; Sneha VS; Sidhanth C; Bindhya S; Manasa P; Ganesan TS
    Int J Cancer; 2016 Aug; 139(4):729-35. PubMed ID: 26934471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.
    Döme B; Hendrix MJ; Paku S; Tóvári J; Tímár J
    Am J Pathol; 2007 Jan; 170(1):1-15. PubMed ID: 17200177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2.
    Reiss Y; Knedla A; Tal AO; Schmidt MHH; Jugold M; Kiessling F; Burger AM; Wolburg H; Deutsch U; Plate KH
    J Pathol; 2009 Mar; 217(4):571-80. PubMed ID: 19116989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.